Actuate Therapeutics, Inc. (ACTU) — DEFA14A Filings
All DEFA14A filings from Actuate Therapeutics, Inc.. Browse 2 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (2)
- DEFA14A Filing — May 6, 2026
-
Actuate Therapeutics Files Proxy Materials
— Apr 9, 2025 Risk: low
Actuate Therapeutics, Inc. filed a Definitive Additional Materials proxy statement on April 9, 2025. This filing relates to the company's solicitation of proxie
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX